These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap]. Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121 [TBL] [Abstract][Full Text] [Related]
44. Hyperresponsiveness as a determinant of the outcome in chronic obstructive pulmonary disease. Postma DS; Wempe JB; Renkema TE; van der Mark TW; Koëter GH Am Rev Respir Dis; 1991 Jun; 143(6):1458-62. PubMed ID: 2048838 [TBL] [Abstract][Full Text] [Related]
45. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Fabbri LM; Romagnoli M; Corbetta L; Casoni G; Busljetic K; Turato G; Ligabue G; Ciaccia A; Saetta M; Papi A Am J Respir Crit Care Med; 2003 Feb; 167(3):418-24. PubMed ID: 12426229 [TBL] [Abstract][Full Text] [Related]
52. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
57. Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey. Kim SH; Moon JY; Lee JH; Ban GY; Kim S; Kim MA; Kim JH; Kim MH; Park CS; Park SY; Kwon HS; Kwon JW; Jung JW; Kang HR; Park JS; Kim TB; Park HW; Cho YS; Yoo KH; Oh YM; Lee BJ; Jang AS; Cho SH; Park HS; Park CS; Yoon HJ; Allergy Asthma Immunol Res; 2018 May; 10(3):225-235. PubMed ID: 29676069 [TBL] [Abstract][Full Text] [Related]
58. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Keatings VM; Collins PD; Scott DM; Barnes PJ Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092 [TBL] [Abstract][Full Text] [Related]
59. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Iwamoto H; Gao J; Koskela J; Kinnula V; Kobayashi H; Laitinen T; Mazur W Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464 [TBL] [Abstract][Full Text] [Related]
60. A new perspective on bronchial asthma and chronic obstructive pulmonary disease overlap: potential diagnostic criteria. Pertseva TO; Konopkina LI; Babenko AO Wiad Lek; 2020; 73(7):1480-1483. PubMed ID: 32759441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]